When combined with semaglutide in CagriSema, results are comparable to Zepbound, though slightly lower in a head-to-head trial
Ahead, well unpack why interest is surging while carefully addressing the lack of FDA approval, limited human research, and growing regulatory scrutiny surrounding its use
Additional risks stem from the largely unregulated nature of the peptide market, where product quality, purity, and dosing can vary significantly
(2011) Angiogenic effects of BPC-157 Hsieh et al
The copper binds via the histidine imidazole ring, the peptide backbone, and deprotonated amide nitrogens, forming a stable, square-planar coordination complex
This makes GHK-Cu suitable for year-round use without the restrictions that accompany many anti-aging treatments